Medindia

X

Assured Pharmacy Reports Same Store Sales for the Month of July 2010

Friday, August 20, 2010 Drug News J E 4
Advertisement


FRISCO, Texas, Aug. 19 Assured Pharmacy (Pink Sheets: APHY), a leading specialty pharmacy providing prescription medications to more than 3,000 sufferers of chronic pain announced that total sales on a same store basis for the month of July 2010 were $1,422,163 which equates to $67,722 per business day . This represents an increase of 1.4 percent compared with total sales of $1,402,374 for June 2010 and an increase of 6.2 percent compared with total sales per business day of $63,744 for June 2010. It also represents an increase of 20.8 percent when compared with total sales of $1,177,551 for the same period one year ago.

"We are very pleased with our sales results in July which marks our fifth consecutive month of revenue per business day growth. The results reflect continued progress in the implementation of our strategies, especially when taking into consideration that the summer months have been historically lower revenue months due to seasonality," said Robert DelVecchio, Chief Executive Officer of Assured Pharmacy. "As these sales figures reflect, we remain on track in our drive for sales and market share growth, improved earnings at the store level and strong cash flow. I believe the transparency of our monthly sales trend is vital to keeping its shareholders informed and have initiated an action plan to inform our shareholders of these sales trends on the third Thursday of each month."

Click Here for Corresponding Video News Release.

About Assured Pharmacy, Inc.

Assured Pharmacy, Inc. is engaged in the business of operating specialty pharmacies that primarily dispense highly regulated pain medication. The Company derives its revenue primarily from the sale of prescription drugs and does not keep in inventory non-prescription drugs or health and beauty related products inventoried at traditional pharmacies. The Company offers physicians the ability to electronically transmit prescriptions to its pharmacies. The majority of the Company's business is derived from repeat business from its customers. "Walk-in" prescriptions from physicians are limited. The Company currently has four operating pharmacies. Three of those pharmacies are wholly owned and the Company has a 94.8% ownership interest in the other pharmacy.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contact: Mr. Robert DelVecchio Chief Executive Officer Assured Pharmacy, Inc. (214) 220-9302 investors@assuredrxservices.com www.assuredrxservices.com

SOURCE Assured Pharmacy, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
ACCF Joins SCAI as New Partner in Accreditation of...
S
Statement from Eli Lilly and Company Regarding App...